Skip to main content
SpringerLink
Log in

Epidemiology of Sarcopenia and Frailty in CKD

  • Chapter
  • First Online:
Recent Advances of Sarcopenia and Frailty in CKD

  • 414 Accesses

Abstract

Chronic kidney disease (CKD) is very common in the elderly. CKD-related metabolic derangements increase the risk of skeletal muscle wasting, so the prevalence of sarcopenia and frailty are substantially higher in CKD patients compared to the general population. Sarcopenia is defined according to the Asian Working Group for Sarcopenia (AWGS), while frailty according to the Japanese version of the Cardiovascular Health Study (J-CHS) in Japan. Sarcopenia and frailty are closely associated with protein-energy wasting. Frailty is also more prevalent in female than in male in CKD patients.

Sarcopenia and frailty are both related to survival prognosis and accelerated progression to end-stage kidney disease in patients with non-dialysis-dependent CKD. In dialysis patients, low muscle strength rather than muscle mass volume is more strongly associated with physical inactivity, inflammation, and total mortality. Frailty is also an independent predictor of cognitive impairment, hospitalization, and mortality in the dialysis population.

Given the convincing relationship between sarcopenia, frailty, and adverse clinical outcomes, we should be more aware of the concept of sarcopenia and frailty and prevent their progressions especially in older patients with advanced CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M. Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol. 2015;26:2621–33.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–82.

    Article  PubMed  Google Scholar 

  3. United States Renal Data System. USRDS annual data report. Epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health; 2015. p. 2015.

    Google Scholar 

  4. Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. An overview of regular dialysis treatment in Japan (as of 31 December 2013). Ther Apher Dial. 2015;19:540–74.

    Article  CAS  PubMed  Google Scholar 

  5. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88:950–7.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, Maddukuri G, Tsai CY, Floyd T, Al-Aly Z. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–81.

    Article  PubMed  Google Scholar 

  8. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, Morgenstern H, Pavkov ME, Saran R, Powe NR, Hsu CY, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165:473–81.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.

    Article  PubMed  Google Scholar 

  10. O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–65.

    Article  PubMed  Google Scholar 

  11. Demoulin N, Beguin C, Labriola L, Jadoul M. Preparing renal replacement therapy in stage 4 CKD patients referred to nephrologists: a difficult balance between futility and insufficiency. A cohort study of 386 patients followed in Brussels. Nephrol Dial Transplant. 2011;26:220–6.

    Article  PubMed  Google Scholar 

  12. Sud M, Tangri N, Levin A, Pintilie M, Levey AS, Naimark DM. CKD stage at nephrology referral and factors influencing the risks of ESRD and death. Am J Kidney Dis. 2014;63:928–36.

    Article  PubMed  Google Scholar 

  13. Obi Y, Kimura T, Nagasawa Y, Yamamoto R, Yasuda K, Sasaki K, Kitamura H, Imai E, Rakugi H, Isaka Y, Hayashi T. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol. 2010;5:1558–65.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Iimori S, Naito S, Noda Y, Sato H, Nomura N, Sohara E, Okado T, Sasaki S, Uchida S, Rai T. Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study. PLoS One. 2018;13:e0190493.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.

    Article  PubMed  Google Scholar 

  16. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101.

    Article  PubMed  Google Scholar 

  17. Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, Amodeo C, Cuppari L, Kamimura MA. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant. 2015;30:1718–25.

    Article  CAS  PubMed  Google Scholar 

  18. Souza VA, Oliveira D, Barbosa SR, Corrêa JODA, Colugnati FAB, Mansur HN, Fernandes NMDS, Bastos MG. Sarcopenia in patients with chronic kidney disease not yet on dialysis: analysis of the prevalence and associated factors. PLoS One. 2017;12:e0176230.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Zhou Y, Hellberg M, Svensson P, Höglund P, Clyne N. Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5. Nephrol Dial Transplant. 2018;33:342–8.

    Article  CAS  PubMed  Google Scholar 

  20. Ishikawa S, Naito S, Iimori S, Takahashi D, Zeniya M, Sato H, Nomura N, Sohara E, Okado T, Uchida S, Rai T. Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease. PLoS One. 2018;13:e0192990.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. D’Alessandro C, Piccoli GB, Barsotti M, Tassi S, Giannese D, Morganti R, Cupisti A. Prevalence and correlates of sarcopenia among elderly CKD outpatients on tertiary care. Nutrients. 2018;10:E1951.

    Article  PubMed  CAS  Google Scholar 

  22. Harada K, Suzuki S, Ishii H, Aoki T, Hirayama K, Shibata Y, Negishi Y, Sumi T, Kawashima K, Kunimura A, Shimbo Y, Tatami Y, Kawamiya T, Yamamoto D, Morimoto R, Yasuda Y, Murohara T. Impact of skeletal muscle mass on long-term adverse cardiovascular outcomes in patients with chronic kidney disease. Am J Cardiol. 2017;119:1275–80.

    Article  PubMed  Google Scholar 

  23. McIntyre CW, Selby NM, Sigrist M, Pearce LE, Mercer TH, Naish PF. Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease. Nephrol Dial Transplant. 2006;21:2210–6.

    Article  PubMed  Google Scholar 

  24. Isoyama N, Quershi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with morality in dialysis patients. Clin J Am Soc Nephrol. 2014;9:1720–8.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33:64–8.

    Article  PubMed  Google Scholar 

  26. Lamarca F, Carrero JJ, Rodrigues JC, Bigogno FG, Fetter RL, Avesani CM. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging. 2014;18:710–7.

    Article  CAS  PubMed  Google Scholar 

  27. Bataille S, Serveaux M, Carreno E, Pedinielli N, Darmon P, Robert A. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr. 2017;36:1654–60.

    Article  PubMed  Google Scholar 

  28. Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C, Kaysen GA, Johansen KL. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017;92:238–47.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Giglio J, Kamimura MA, Lamarca F, Rodrigues J, Santin F, Avesani CM. Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis. J Ren Nutr. 2018;28:197–207.

    Article  PubMed  Google Scholar 

  30. Kamijo Y, Kanda E, Ishibashi Y, Yoshida M. Sarcopenia and frailty in PD: impact on mortality, malnutrition, and inflammation. Perit Dial Int. 2018;38:447–54.

    Article  PubMed  Google Scholar 

  31. Kato A, Ishida J, Endo Y, Takita T, Furuhashi M, Maruyama Y, Odamaki M. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant. 2011;26:1967–76.

    Article  PubMed  Google Scholar 

  32. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty and comorbidity: implications for improving targeting and care. J Gerontrol A Biol Sci Med Sci. 2004;59:225–63.

    Google Scholar 

  33. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001;1:323–36.

    Article  CAS  Google Scholar 

  34. Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Satake S, Senda K, Hong YJ, Miura H, Endo H, Sakurai T, Kondo I, Toba K. Validity of the Kihon checklist for assessing frailty status. Geriatr Gerontol Int. 2016;16:709–15.

    Article  PubMed  Google Scholar 

  36. Satake S, Shimada H, Yamada M, Kim H, Yoshida H, Gondo Y, Matsubayashi K, Matsushita E, Kuzuya M, Kozaki K, Sugimoto K, Senda K, Sakuma M, Endo N, Arai H. Prevalence of frailty among community-dwellers and outpatients in Japan as defined by the Japanese version of the Cardiovascular Health Study criteria. Geriatr Gerontol Int. 2017;17:2629–34.

    Article  PubMed  Google Scholar 

  37. Carrero JJ, Johansen KL, Lindholm B, Stenvinkel P, Cuppari L, Avesani CM. Screening for muscle wasting and dysfunction in patients with chronic kidney disease. Kidney Int. 2016;90:53–60.

    Article  PubMed  Google Scholar 

  38. Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaun B. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis. 2012;60:912–21.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hiraki K, Yasuda T, Hotta C, Izawa KP, Morio Y, Watanabe S, Sakurada T, Shibagaki Y, Kimura K. Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol. 2013;17:2252–31.

    Article  CAS  Google Scholar 

  40. Lee S, Lee S, Harada K, Bae S, Makizako H, Doi T, Tsutsumimoto K, Hotta R, Nakakubo S, Park H, Suzuki T, Shimada H. Geriatr Gerontol Int. 2017;17:1527–33.

    PubMed  Google Scholar 

  41. Lee S, Lee S, Bae S, Harada K, Jung S, Imaoka M, Makizako H, Doi T, Shimada H. Relationship between chronic kidney disease without diabetes mellitus and components of frailty in community-dwelling Japanese older adults. Geriatr Gerontol Int. 2018;18:286–92.

    Article  PubMed  Google Scholar 

  42. Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaum B. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis. 2012;60:912–21.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Lee SJ, Son H, Shin SK. Influence of frailty on health-related quality of life in pre-dialysis patients with chronic kidney disease in Korea: a cross-sectional study. Health Qual Life Outcomes. 2015;13:70.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Shlipak MG, Stehman-Breen C, Fried LF, Song X, Siscovick D, Fried LP, Psaty BM, Newman AB. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis. 2004;43:861–7.

    Article  PubMed  Google Scholar 

  45. Takeuchi H, Uchida HA, Kakio Y, Okuyama Y, Okuyama M, Umebayashi R, Wada K, Sugiyama H, Sugimoto K, Rakugi H, Wada J. The prevalence of frailty and its associated factors in Japanese hemodialysis patients. Aging Dis. 2018;9:192–207.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Lee SY, Yang DH, Hwang E, Kang SH, Park SH, Kim TW, Lee DH, Park K, Kim JC. The prevalence, association, and clinical outcomes of frailty in maintenance dialysis patients. J Ren Nutr. 2017;27:106–12.

    Article  PubMed  Google Scholar 

  47. Johansen KL, Delgado C, Kaysen GA, Chertow GM, Chiang J, Dalrymple LS, Segal MR, Grimes BA. Frailty among patients receiving hemodialysis: evolution of components and associations with mortality. J Gerontol A Biol Sci Med Sci. 2019;74:380–6.

    Article  PubMed  Google Scholar 

  48. McAdams-DeMarco MA, Tan J, Salter ML, Gross A, Meoni LA, Jaar BG, Kao WH, Parekh RS, Segev DL, Sozio SM. Frailty and cognitive function in incident hemodialysis patients. Clin J Am Soc Nephrol. 2015;10:2181–9.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Delgado C, Shieh S, Grimes B, Chertow GM, Dalrymple LS, Kaysen GA, Kornak J, Johansen KL. Association of self-reported frailty with falls and fractures among patients mew to dialysis. Am J Nephrol. 2015;42:134–40.

    Article  PubMed  Google Scholar 

  50. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.

    Article  CAS  PubMed  Google Scholar 

  51. Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, Chmielewski M, Cordeiro AC, Espinosa-Cuevas A, Fiaccadori E, Guebre-Egziabher F, Hand RK, Hung AM, Ikizler TA, Johansson LR, Kalantar-Zadeh K, Karupaiah T, Lindholm B, Marckmann P, Mafra D, Parekh RS, Park J, Russo S, Saxena A, Sezer S, Teta D, Ter Wee PM, Verseput C, Wang AYM, Xu H, Lu Y, Molnar MZ, Kovesdy CP. Global prevalence of protein-energy wasting in kidney disease: a meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28:380–92.

    Article  PubMed  Google Scholar 

  52. Yasui S, Shirai Y, Tanimura M, Matsuura S, Saito Y, Miyata K, Ishikawa E, Miki C, Hamada Y. Prevalence of protein-energy wasting (PEW) and evaluation of diagnostic criteria in Japanese maintenance hemodialysis patients. Asia Pac J Clin Nutr. 2016;25:292–9.

    CAS  PubMed  Google Scholar 

  53. Takahashi H, Inoue K, Shimizu K, Hiraga K, Takahashi E, Otaki K, Yoshikawa T, Furuta K, Tokunaga C, Sakakibara T, Ito Y, Tokai Renal Nutrition Study Group. Comparison of nutritional risk scores for predicting mortality in Japanese chronic hemodialysis patients. J Ren Nutr. 2017;27:201–6.

    Article  PubMed  Google Scholar 

Download references

Disclosures

I declare that I have no competing interests.

Author information

Authors and Affiliations

  1. Blood Purification Unit, Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan

    Akihiko Kato

Authors
  1. Akihiko Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akihiko Kato .

Editor information

Editors and Affiliations

  1. Blood Purification Unit, Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan

    Akihiko Kato

  2. Medical Science, Kawasaki Medical School, Kurashiki, Japan

    Eiichiro Kanda

  3. Department of Nephrology, Tokyo Medical University, Tokyo, Japan

    Yoshihiko Kanno

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kato, A. (2020). Epidemiology of Sarcopenia and Frailty in CKD. In: Kato, A., Kanda, E., Kanno, Y. (eds) Recent Advances of Sarcopenia and Frailty in CKD. Springer, Singapore. https://doi.org/10.1007/978-981-15-2365-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-2365-6_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-2364-9

  • Online ISBN: 978-981-15-2365-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation